Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients

Author： Peterson T.C.   Huet P.-M.  

Publisher： Elsevier

ISSN： 0928-4346

Source： International Hepatology Communications, Vol.7, Iss.2, 1997-06, pp. : 94-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ursodeoxycholic acid and histological progression in primary biliary cirrhosis

By Chan C.-W.   V. Papatheodoridis G.   Goulis J.   K. Burroughs A.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1094-1095

Elsevier

Access to resources Recommend Favorite

Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 85-88

Karger

Access to resources Recommend Favorite

Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid

By Kaplan Marshall   Bonder Alan   Ruthazer Robin   Bonis Peter  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3207-3217

Springer Publishing Company

Access to resources Recommend Favorite

Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid

By  

Digestive Diseases, Vol. 33, Iss. 2, 2015-0 ,pp. : 125-133

Karger

Access to resources Recommend Favorite

What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?

By  

Digestive Diseases, Vol. 35, Iss. 4, 2017-05 ,pp. : 359-366

Karger

Access to resources Recommend Favorite